Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1927 1
1929 1
1934 2
1936 1
1937 2
1939 1
1940 2
1941 3
1945 1
1946 8
1947 2
1948 1
1950 5
1951 6
1952 1
1953 14
1954 8
1955 2
1956 2
1957 5
1958 6
1959 5
1960 9
1961 5
1962 18
1963 18
1964 5
1965 15
1966 10
1967 8
1968 13
1969 31
1970 18
1971 22
1972 25
1973 31
1974 38
1975 24
1976 47
1977 46
1978 38
1979 49
1980 63
1981 71
1982 65
1983 82
1984 86
1985 102
1986 133
1987 131
1988 163
1989 173
1990 172
1991 194
1992 243
1993 223
1994 315
1995 304
1996 342
1997 364
1998 375
1999 437
2000 545
2001 585
2002 616
2003 664
2004 770
2005 948
2006 1019
2007 1133
2008 1291
2009 1408
2010 1703
2011 1824
2012 1970
2013 2074
2014 2194
2015 2272
2016 2339
2017 2385
2018 2474
2019 2558
2020 2930
2021 3219
2022 3040
2023 2848
2024 2862
2025 3054
2026 1206

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

48,651 results

Results by year

Filters applied: . Clear all
Page 1
Homologous recombination deficiency and hemizygosity drive resistance in breast cancer.
Safonov A, Lee M, Brown DN, Boscolo Bielo L, Mehine M, Bandlamudi C, O'Leary B, Shao H, Vicente L, Muldoon D, Zhu A, Ros S, Marra A, Selenica P, Bieche I, Wubbenhorst B, Ferraro E, Courtois L, El Botty R, Ahmed M, Moiso E, An JA, Donoghue MTA, Will M, Pareja F, Nizialek E, Lukashchuk N, Sofianopoulou E, Liu Y, Huang X, Chappey C, Staniszewska AD, Ross D, Mandelker D, Ladanyi M, Schultz N, Berger MF, Scaltriti M, Reis-Filho JS, Li BT, Offit K, Norton L, Shen R, Maxwell KN, Couch F, Domchek SM, Marangoni E, Shah S, Albertella MR, Serra V, Weigelt B, Solit DB, Nathanson KL, Robson ME, Turner NC, Chandarlapaty S, Razavi P. Safonov A, et al. Among authors: lee m. Nature. 2026 Apr;652(8110):752-762. doi: 10.1038/s41586-026-10197-0. Epub 2026 Mar 4. Nature. 2026. PMID: 41781623 Free PMC article.
Combating respiratory diseases with mucosal vaccines.
Tang PCH, Ling Z, Lee M, King NJC, Mahalingam S. Tang PCH, et al. Among authors: lee m. J Virol. 2026 Apr 15:e0014626. doi: 10.1128/jvi.00146-26. Online ahead of print. J Virol. 2026. PMID: 41983630 Free article. Review.
Ribosome Molecular Aging Shapes Translation Dynamics.
Botello JF, Jiang L, Metzger PJ, Comi TJ, Abu-Alfa AA, Yu Q, Ebert MS, Lee M, Wiesner LW, Butani M, Weaver CJ, Košmrlj A, Cristea IM, Brangwynne CP. Botello JF, et al. Among authors: lee m. bioRxiv [Preprint]. 2026 Mar 9:2026.03.08.710403. doi: 10.64898/2026.03.08.710403. bioRxiv. 2026. PMID: 41890057 Free PMC article. Preprint.
The Wealth of Wealthholders.
Ameriks J, Caplin A, Lee M, Shapiro MD, Tonetti C. Ameriks J, et al. Among authors: lee m. Rev Income Wealth. 2026 May;72(2):e70062. doi: 10.1111/roiw.70062. Epub 2026 Mar 20. Rev Income Wealth. 2026. PMID: 41868606 Free PMC article.
Clinical Impact of Postrecanalization Hemorrhagic Transformation and Its Prediction Using Baseline Noncontrast CT.
Ha HJ, Ryu WS, Sunwoo L, Lee M, Kang K, Kim JG, Lee SJ, Cha JK, Park TH, Lee JY, Lee K, Kwon DH, Lee J, Park HK, Hong KS, Lee M, Oh MS, Yu KH, Gwak DS, Kim DE, Kim H, Kim JT, Kim JG, Choi JC, Kim WJ, Weon YC, Kwon JH, Yum KS, Shin DI, Hong JH, Sohn SI, Lee SH, Kim C, Jeong HB, Park KY, Kim CK, Kang J, Kim JY, Bae HJ, Lin L, Parsons M, Kim BJ. Ha HJ, et al. Among authors: lee m. Stroke. 2026 May;57(5):1325-1335. doi: 10.1161/STROKEAHA.125.053938. Epub 2026 Mar 9. Stroke. 2026. PMID: 41797706
Phase II study of olaparib and durvalumab in patients with metastatic castration-resistant prostate cancer.
Li C, Madan RA, Lee MJ, Lee S, Sato N, Rastogi S, Shrestha R, Aragon-Ching JB, Goswami M, Donahue RN, Cordes LM, Baj A, Seo CCY, Terrigino NT, Bright JR, Hennigan ST, King IM, Trostel SY, Fenimore JM, Liu Y, Calzone KA, Schlom J, Gulley JL, Dahut WL, Figg WD, Sowalsky AG, Lee JM, Karzai F. Li C, et al. Among authors: lee mj. J Immunother Cancer. 2026 Mar 25;14(3):e014365. doi: 10.1136/jitc-2025-014365. J Immunother Cancer. 2026. PMID: 41881502 Free PMC article. Clinical Trial.
Building capacity in imaging data management.
Velasquez SM, Fletcher G, Burel JM, Parsons M, Swedlow J, Hartley M, Bagia S, Beckett A, Crichton JH, Cross SJ, Foulkes DM, Grimshaw J, Held M, Ho K, Jones M, Lee M, Marcello M, Marcotti S, Markus R, McConnell G, Thomas SG, West SJ, Wheeler A, Küpcü Yoldaş A. Velasquez SM, et al. Among authors: lee m. J Microsc. 2026 Mar 24. doi: 10.1111/jmi.70078. Online ahead of print. J Microsc. 2026. PMID: 41873830 Free article.
48,651 results
You have reached the last available page of results. Please see the User Guide for more information.